Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum

NCT01042548 is registered in ClinicalTrials.gov with University of Pittsburgh as lead sponsor.

NCT NCT01042548
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01042548 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Proteomics and Radiomics Research of Breast Cancer Markers in Tissue, Interstitial Fluid and Serum
Lead sponsor
University of Pittsburgh
Phase
Observational
Overall status
Recruiting
Start date
February 3, 2010
Completion date
April 30, 2030
Enrollment
300 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer